Pharming Group N.V. (PHAR) Form 10-K Annual Reports
Pharming Group N.V. (PHAR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PHAR
CIK: 1828316
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: P7
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte Accountants B.V.
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerAloisia Zwama-Bombeeck
Audit LocationEindhoven, Netherlands
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-14 | 2026-10-14 | 6-K | 0001828316-26-000045 | View SEC Doc Filr Page |
| 6-K | 2026-09-29 | 2026-09-29 | 6-K | 0001828316-26-000043 | View SEC Doc Filr Page |
| 6-K | 2026-09-25 | 2026-09-25 | 6-K | 0001828316-26-000041 | View SEC Doc Filr Page |
| 6-K | 2026-09-22 | 2026-09-22 | 6-K | 0001828316-26-000039 | View SEC Doc Filr Page |
| 6-K | 2026-09-11 | 2026-09-11 | 6-K | 0001828316-26-000037 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-13 | 6-K | 0001828316-26-000035 | View SEC Doc Filr Page |
| 6-K | 2026-07-30 | 2026-07-30 | 6-K | 0001828316-26-000033 | View SEC Doc Filr Page |
| 6-K | 2026-06-04 | 2026-06-04 | 6-K | 0001828316-26-000031 | View SEC Doc Filr Page |
| 6-K | 2026-05-28 | 2026-05-28 | 6-K | 0001828316-26-000029 | View SEC Doc Filr Page |
| 6-K | 2026-05-22 | 2026-05-22 | 6-K | 0001828316-26-000027 | View SEC Doc Filr Page |
| 6-K | 2026-05-07 | 2026-05-07 | 6-K | 0001828316-26-000025 | View SEC Doc Filr Page |
| 6-K | 2026-05-07 | 2026-05-07 | 6-K | 0001828316-26-000023 | View SEC Doc Filr Page |
| 6-K | 2026-04-16 | 2026-04-16 | 6-K | 0001828316-26-000021 | View SEC Doc Filr Page |
| 20-F/A | 2026-04-13 | 2025-12-31 | 20-F/A | 0001828316-26-000019 | View SEC Doc Filr Page |
| 6-K | 2026-04-02 | 2026-04-02 | 6-K | 0001828316-26-000017 | View SEC Doc Filr Page |
| 20-F | 2026-04-02 | 2025-12-31 | 20-F | 0001828316-26-000015 | View SEC Doc Filr Page |
| 6-K | 2026-03-27 | 2026-03-27 | 6-K | 0001828316-26-000012 | View SEC Doc Filr Page |
| 6-K | 2026-03-24 | 2026-03-24 | 6-K | 0001828316-26-000010 | View SEC Doc Filr Page |
| 6-K | 2026-03-12 | 2026-03-12 | 6-K | 0001828316-26-000008 | View SEC Doc Filr Page |
| 6-K | 2026-02-03 | 2026-02-03 | 6-K | 0001828316-26-000006 | View SEC Doc Filr Page |
| 6-K | 2026-02-02 | 2026-02-01 | 6-K | 0001828316-26-000004 | View SEC Doc Filr Page |
| 6-K | 2026-01-08 | 2026-01-08 | 6-K | 0001828316-26-000002 | View SEC Doc Filr Page |
| 6-K | 2025-11-06 | 2025-11-06 | 6-K | 0001828316-25-000049 | View SEC Doc Filr Page |
| 6-K | 2025-10-22 | 2025-10-20 | 6-K | 0001828316-25-000047 | View SEC Doc Filr Page |
| 6-K | 2025-10-06 | 2025-10-06 | 6-K | 0001828316-25-000045 | View SEC Doc Filr Page |